SCHEDULE 13D

Company

Inhibitor Therapeutics, Inc.

Filed

July 7, 2014

Accession Number

0001571049-14-002888

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →